XPO1 and Hutchinson-Gilford progeria syndrome: Further investigation of the overall effect of selinexor on LmnaG609G/G609G mouse physiology, with emphasis in cardiovascular function is warranted, to determine its therapeutic utility for HGPS and aging‐associated disorders characterized by CRM1 overactivity.